Loading clinical trials...
Loading clinical trials...
Phase II Study of Vinorelbine + Cyclofosfamide Association Among Patients Reached of Refractory Tumours or in Relapse
Conditions
Interventions
Vinorelbine, cyclofosfamide
Locations
1
France
Institut Gustave-Roussy
Villejuif, France
Start Date
June 1, 2003
Last Updated
September 8, 2006
NCT05440240
NCT04910126
NCT01491594
NCT00132158
Lead Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions